Focus Partners Advisor Solutions’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Focus Partners Advisor Solutions's PFE Position: Q2 2026 in Review
Focus Partners Advisor Solutions increased its Pfizer (PFE) stake by 20% in Q2 2026, buying an estimated $621K and bringing the position to 145,419 shares worth $3.5M. The position accounts for 0.03% of the portfolio, ranked #256.
Focus Partners Advisor Solutions first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.92M in Q4 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Focus Partners Advisor Solutions held 145,419 shares of Pfizer worth $3.5M as of Q2 2026.
- Focus Partners Advisor Solutions bought 23,735 Pfizer shares in Q2 2026, an estimated $621K.
- Pfizer made up 0.03% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #256 holding.
- Focus Partners Advisor Solutions first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
- Focus Partners Advisor Solutions's Pfizer position peaked at $4.92M in Q4 2025.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.